$ALNY Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ALNYLAM PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ALNYLAM PHARMACEUTICALS, INC.. Get notifications about new insider transactions in ALNYLAM PHARMACEUTICALS, INC. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 17 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | M | 7.10 | 33,979 | 241,251 | 67,957 | |
May 17 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 134.37 | 1,023 | 137,461 | 214,765 | 215.8 K to 214.8 K (-0.47 %) |
May 17 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 133.56 | 1,624 | 216,901 | 215,788 | 217.4 K to 215.8 K (-0.75 %) |
May 17 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 132.32 | 3,481 | 460,606 | 217,412 | 220.9 K to 217.4 K (-1.58 %) |
May 17 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 131.18 | 11,203 | 1,469,610 | 220,893 | 232.1 K to 220.9 K (-4.83 %) |
May 17 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 130.34 | 9,121 | 1,188,831 | 232,096 | 241.2 K to 232.1 K (-3.78 %) |
May 17 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 129.32 | 4,512 | 583,492 | 241,217 | 245.7 K to 241.2 K (-1.84 %) |
May 17 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 128.30 | 3,015 | 386,825 | 245,729 | 248.7 K to 245.7 K (-1.21 %) |
May 17 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | M | 7.10 | 33,979 | 241,251 | 248,744 | 214.8 K to 248.7 K (+15.82 %) |
Apr 21 2021 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Sell | S | 138.48 | 107 | 14,817 | 14,119 | 14.2 K to 14.1 K (-0.75 %) |
Apr 21 2021 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Sell | S | 137.60 | 530 | 72,928 | 14,226 | 14.8 K to 14.2 K (-3.59 %) |
Apr 21 2021 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Sell | S | 136.84 | 1,892 | 258,901 | 14,756 | 16.6 K to 14.8 K (-11.36 %) |
Apr 21 2021 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Sell | S | 135.41 | 203 | 27,488 | 16,648 | 16.9 K to 16.6 K (-1.20 %) |
Apr 21 2021 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Payment of Exercise | F | 134.56 | 85 | 11,438 | 16,851 | 16.9 K to 16.9 K (-0.50 %) |
Apr 21 2021 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Payment of Exercise | F | 131.75 | 2,266 | 298,546 | 16,936 | 19.2 K to 16.9 K (-11.80 %) |
Apr 21 2021 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Sell | S | 140.02 | 417 | 58,388 | 19,202 | 19.6 K to 19.2 K (-2.13 %) |
Apr 21 2021 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Sell | S | 138.64 | 622 | 86,234 | 19,619 | 20.2 K to 19.6 K (-3.07 %) |
Apr 21 2021 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Sell | S | 137.60 | 989 | 136,086 | 20,241 | 21.2 K to 20.2 K (-4.66 %) |
Apr 21 2021 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Sell | S | 136.76 | 1,678 | 229,483 | 21,230 | 22.9 K to 21.2 K (-7.32 %) |
Apr 21 2021 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Grant | A | 0.00 | 5,083 | 0 | 22,908 | 17.8 K to 22.9 K (+28.52 %) |
Apr 21 2021 | ALNY | ALNYLAM PHARMACEUT ... | Poulton Jeffrey V. | Chief Financial Off ... | Buy | J | 0.00 | 38 | 0 | 38 | 0 to 38 |
Apr 21 2021 | ALNY | ALNYLAM PHARMACEUT ... | Poulton Jeffrey V. | Chief Financial Off ... | Payment of Exercise | F | 134.49 | 50 | 6,725 | 3,135 | 3.2 K to 3.1 K (-1.57 %) |
Apr 21 2021 | ALNY | ALNYLAM PHARMACEUT ... | Poulton Jeffrey V. | Chief Financial Off ... | Payment of Exercise | F | 131.75 | 1,333 | 175,623 | 3,185 | 4.5 K to 3.2 K (-29.50 %) |
Apr 21 2021 | ALNY | ALNYLAM PHARMACEUT ... | Poulton Jeffrey V. | Chief Financial Off ... | Grant | A | 0.00 | 4,518 | 0 | 4,518 | 0 to 4.5 K |
Apr 21 2021 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | President & COO | Payment of Exercise | F | 134.49 | 85 | 11,432 | 11,023 | 11.1 K to 11 K (-0.77 %) |
Apr 21 2021 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | President & COO | Payment of Exercise | F | 131.75 | 2,266 | 298,546 | 11,108 | 13.4 K to 11.1 K (-16.94 %) |
Apr 21 2021 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | President & COO | Grant | A | 0.00 | 5,083 | 0 | 13,374 | 8.3 K to 13.4 K (+61.31 %) |
Apr 21 2021 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Payment of Exercise | F | 134.42 | 75 | 10,081 | 6,866 | 6.9 K to 6.9 K (-1.08 %) |
Apr 21 2021 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Payment of Exercise | F | 131.75 | 2,014 | 265,345 | 6,941 | 9 K to 6.9 K (-22.49 %) |
Apr 21 2021 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Grant | A | 0.00 | 4,518 | 0 | 8,955 | 4.4 K to 9 K (+101.83 %) |
Apr 21 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Payment of Exercise | F | 134.62 | 270 | 36,347 | 214,765 | 215 K to 214.8 K (-0.13 %) |
Apr 21 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Payment of Exercise | F | 131.75 | 7,237 | 953,475 | 215,035 | 222.3 K to 215 K (-3.26 %) |
Apr 21 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Grant | A | 0.00 | 16,236 | 0 | 222,272 | 206 K to 222.3 K (+7.88 %) |
Feb 26 2021 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Option Exercise | A | 151.59 | 28,800 | 4,365,792 | 28,800 | |
Feb 26 2021 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Option Exercise | A | 151.59 | 17,846 | 2,705,275 | 17,846 | |
Feb 26 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | M | 7.10 | 33,979 | 241,251 | 101,936 | |
Feb 26 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | A | 151.59 | 79,998 | 12,126,897 | 79,998 | |
Feb 26 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 154.59 | 599 | 92,599 | 206,036 | 206.6 K to 206 K (-0.29 %) |
Feb 26 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 153.33 | 431 | 66,085 | 206,635 | 207.1 K to 206.6 K (-0.21 %) |
Feb 26 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 152.46 | 1,138 | 173,499 | 207,066 | 208.2 K to 207.1 K (-0.55 %) |
Feb 26 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 151.31 | 1,415 | 214,104 | 208,204 | 209.6 K to 208.2 K (-0.68 %) |
Feb 26 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 150.22 | 2,054 | 308,552 | 209,619 | 211.7 K to 209.6 K (-0.97 %) |
Feb 26 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 148.96 | 1,364 | 203,181 | 211,673 | 213 K to 211.7 K (-0.64 %) |
Feb 26 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 148.00 | 4,375 | 647,500 | 213,037 | 217.4 K to 213 K (-2.01 %) |
Feb 26 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 146.98 | 6,097 | 896,137 | 217,412 | 223.5 K to 217.4 K (-2.73 %) |
Feb 26 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 146.13 | 9,376 | 1,370,115 | 223,509 | 232.9 K to 223.5 K (-4.03 %) |
Feb 26 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 145.15 | 6,129 | 889,624 | 232,885 | 239 K to 232.9 K (-2.56 %) |
Feb 26 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 143.88 | 1,001 | 144,024 | 239,014 | 240 K to 239 K (-0.42 %) |
Feb 26 2021 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | M | 7.10 | 33,979 | 241,251 | 240,015 | 206 K to 240 K (+16.49 %) |
Feb 16 2021 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Option Exercise | A | 119.13 | 8,334 | 992,829 | 25,000 | |
Feb 16 2021 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Payment of Exercise | F | 152.53 | 92 | 14,033 | 17,825 | 17.9 K to 17.8 K (-0.51 %) |
Feb 16 2021 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Payment of Exercise | F | 156.00 | 1,618 | 252,408 | 17,917 | 19.5 K to 17.9 K (-8.28 %) |
Feb 16 2021 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Grant | A | 0.00 | 5,416 | 0 | 19,535 | 14.1 K to 19.5 K (+38.36 %) |
Jan 15 2021 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Option Exercise | M | 85.00 | 6,000 | 510,000 | 19,000 | |
Jan 15 2021 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Option Exercise | M | 77.40 | 3,027 | 234,290 | 2,164 | |
Jan 15 2021 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Sell | S | 174.00 | 1,027 | 178,698 | 2,234 | 3.3 K to 2.2 K (-31.49 %) |
Jan 15 2021 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Sell | S | 170.00 | 3,000 | 510,000 | 3,261 | 6.3 K to 3.3 K (-47.92 %) |
Jan 15 2021 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Sell | S | 169.00 | 5,000 | 845,000 | 6,261 | 11.3 K to 6.3 K (-44.40 %) |
Jan 15 2021 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Buy | M | 85.00 | 6,000 | 510,000 | 11,261 | 5.3 K to 11.3 K (+114.05 %) |
Jan 15 2021 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Buy | M | 77.40 | 3,027 | 234,290 | 5,261 | 2.2 K to 5.3 K (+135.50 %) |
Jan 13 2021 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Option Exercise | M | 77.40 | 13,000 | 1,006,200 | 5,191 | |
Jan 13 2021 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Option Exercise | M | 42.22 | 1,941 | 81,949 | 2,370 | |
Jan 13 2021 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Sell | S | 165.00 | 3,000 | 495,000 | 2,234 | 5.2 K to 2.2 K (-57.32 %) |
Jan 13 2021 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Sell | S | 159.00 | 11,941 | 1,898,619 | 5,234 | 17.2 K to 5.2 K (-69.53 %) |
Jan 13 2021 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Buy | M | 77.40 | 13,000 | 1,006,200 | 17,175 | 4.2 K to 17.2 K (+311.38 %) |
Jan 13 2021 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Buy | M | 42.22 | 1,941 | 81,949 | 4,175 | 2.2 K to 4.2 K (+86.88 %) |
Jan 13 2021 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Sell | S | 154.00 | 758 | 116,732 | 2,234 | 3 K to 2.2 K (-25.33 %) |
Jan 13 2021 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | President & COO | Option Exercise | M | 42.22 | 3,125 | 131,938 | 0 | |
Jan 13 2021 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | President & COO | Sell | S | 161.00 | 3,125 | 503,125 | 4,820 | 7.9 K to 4.8 K (-39.33 %) |
Jan 13 2021 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | President & COO | Buy | M | 42.22 | 3,125 | 131,938 | 7,945 | 4.8 K to 7.9 K (+64.83 %) |
Dec 22 2020 | ALNY | ALNYLAM PHARMACEUT ... | PAUL STEVEN M | Director | Option Exercise | M | 9.30 | 15,000 | 139,500 | 0 | |
Dec 22 2020 | ALNY | ALNYLAM PHARMACEUT ... | PAUL STEVEN M | Director | Sell | S | 140.00 | 15,000 | 2,100,000 | 1,000 | 16 K to 1,000 (-93.75 %) |
Dec 22 2020 | ALNY | ALNYLAM PHARMACEUT ... | PAUL STEVEN M | Director | Buy | M | 9.30 | 15,000 | 139,500 | 16,000 | 1,000 to 16 K (+1,500.00 %) |
Dec 22 2020 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILLIP A | Director | Gift | G | 0.00 | 235,633 | 0 | 266,899 | 31.3 K to 266.9 K (+753.64 %) |
Dec 22 2020 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILLIP A | Director | Gift | G | 0.00 | 235,633 | 0 | 0 | 235.6 K to 0 (-100.00 %) |
Nov 30 2020 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILLIP A | Director | Option Exercise | M | 9.30 | 30,000 | 279,000 | 0 | |
Nov 30 2020 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILLIP A | Director | Sell | S | 127.44 | 645 | 82,199 | 235,633 | 236.3 K to 235.6 K (-0.27 %) |
Nov 30 2020 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILLIP A | Director | Sell | S | 126.16 | 2,117 | 267,081 | 236,278 | 238.4 K to 236.3 K (-0.89 %) |
Nov 30 2020 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILLIP A | Director | Sell | S | 125.05 | 15,715 | 1,965,161 | 238,395 | 254.1 K to 238.4 K (-6.18 %) |
Nov 30 2020 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILLIP A | Director | Sell | S | 124.30 | 11,523 | 1,432,309 | 254,110 | 265.6 K to 254.1 K (-4.34 %) |
Nov 30 2020 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILLIP A | Director | Buy | M | 9.30 | 30,000 | 279,000 | 265,633 | 235.6 K to 265.6 K (+12.73 %) |
Nov 20 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | M | 9.14 | 34,765 | 317,752 | 0 | |
Nov 20 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 126.62 | 102 | 12,915 | 197,589 | 197.7 K to 197.6 K (-0.05 %) |
Nov 20 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 125.35 | 10,187 | 1,276,940 | 197,691 | 207.9 K to 197.7 K (-4.90 %) |
Nov 20 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 124.49 | 5,489 | 683,326 | 207,878 | 213.4 K to 207.9 K (-2.57 %) |
Nov 20 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 123.55 | 18,987 | 2,345,844 | 213,367 | 232.4 K to 213.4 K (-8.17 %) |
Nov 20 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | M | 9.14 | 34,765 | 317,752 | 232,354 | 197.6 K to 232.4 K (+17.59 %) |
Oct 01 2020 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Option Exercise | M | 42.22 | 971 | 40,996 | 3,338 | |
Oct 01 2020 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Sell | S | 140.00 | 971 | 135,940 | 14,119 | 15.1 K to 14.1 K (-6.43 %) |
Oct 01 2020 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Buy | M | 42.22 | 971 | 40,996 | 15,090 | 14.1 K to 15.1 K (+6.88 %) |
Sep 11 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Option Exercise | M | 9.14 | 44,530 | 407,004 | 0 | |
Sep 11 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Gift | G | 0.00 | 3,176 | 0 | 0 | 3.2 K to 0 (-100.00 %) |
Sep 11 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Gift | G | 0.00 | 155 | 0 | 3,176 | 3.3 K to 3.2 K (-4.65 %) |
Sep 11 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Gift | G | 0.00 | 155 | 0 | 3,331 | 3.5 K to 3.3 K (-4.45 %) |
Sep 11 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Gift | G | 0.00 | 155 | 0 | 155 | 0 to 155 |
Sep 11 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Sell | S | 124.38 | 3,346 | 416,175 | 70,343 | 73.7 K to 70.3 K (-4.54 %) |
Sep 11 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Sell | S | 123.39 | 27,109 | 3,344,980 | 73,689 | 100.8 K to 73.7 K (-26.89 %) |
Sep 11 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Sell | S | 122.66 | 14,075 | 1,726,440 | 100,798 | 114.9 K to 100.8 K (-12.25 %) |
Sep 11 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Buy | M | 9.14 | 44,530 | 407,004 | 114,873 | 70.3 K to 114.9 K (+63.30 %) |
Sep 11 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Gift | G | 0.00 | 3,176 | 0 | 65,412 | 62.2 K to 65.4 K (+5.10 %) |
Aug 21 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | M | 9.14 | 34,765 | 317,752 | 34,765 | |
Aug 21 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 136.86 | 8,542 | 1,169,058 | 197,589 | 206.1 K to 197.6 K (-4.14 %) |
Aug 21 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 136.07 | 21,448 | 2,918,429 | 206,131 | 227.6 K to 206.1 K (-9.42 %) |
Aug 21 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 135.09 | 4,775 | 645,055 | 227,579 | 232.4 K to 227.6 K (-2.06 %) |
Aug 21 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | M | 9.14 | 34,765 | 317,752 | 232,354 | 197.6 K to 232.4 K (+17.59 %) |
Aug 11 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Option Exercise | M | 96.45 | 1,036 | 99,922 | 46,589 | |
Aug 11 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Option Exercise | M | 88.95 | 1,124 | 99,980 | 38,876 | |
Aug 11 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Option Exercise | M | 63.00 | 1,587 | 99,981 | 88,413 | |
Aug 11 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Option Exercise | M | 42.22 | 1,184 | 49,988 | 23,816 | |
Aug 11 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Buy | M | 42.22 | 1,184 | 49,988 | 67,167 | 66 K to 67.2 K (+1.79 %) |
Aug 11 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Buy | M | 88.95 | 1,124 | 99,980 | 65,983 | 64.9 K to 66 K (+1.73 %) |
Aug 11 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Buy | M | 96.45 | 1,036 | 99,922 | 64,859 | 63.8 K to 64.9 K (+1.62 %) |
Aug 11 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Buy | M | 63.00 | 1,587 | 99,981 | 63,823 | 62.2 K to 63.8 K (+2.55 %) |
Jul 14 2020 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Option Exercise | M | 119.13 | 6,250 | 744,563 | 7,500 | |
Jul 14 2020 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Option Exercise | M | 77.40 | 23,809 | 1,842,817 | 18,191 | |
Jul 14 2020 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Option Exercise | M | 42.22 | 1,941 | 81,949 | 4,311 | |
Jul 14 2020 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Option Exercise | M | 119.13 | 3,750 | 446,738 | 5,416 | |
Jul 14 2020 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Sell | S | 162.24 | 9,530 | 1,546,147 | 2,992 | 12.5 K to 3 K (-76.11 %) |
Jul 14 2020 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Sell | S | 161.32 | 15,618 | 2,519,496 | 12,522 | 28.1 K to 12.5 K (-55.50 %) |
Jul 14 2020 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Sell | S | 160.52 | 14,236 | 2,285,163 | 28,140 | 42.4 K to 28.1 K (-33.59 %) |
Jul 14 2020 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Sell | S | 159.22 | 1,061 | 168,932 | 42,376 | 43.4 K to 42.4 K (-2.44 %) |
Jul 14 2020 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Sell | S | 158.27 | 2,323 | 367,661 | 43,437 | 45.8 K to 43.4 K (-5.08 %) |
Jul 14 2020 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Sell | S | 157.16 | 4,482 | 704,391 | 45,760 | 50.2 K to 45.8 K (-8.92 %) |
Jul 14 2020 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Buy | M | 119.13 | 6,250 | 744,563 | 50,242 | 44 K to 50.2 K (+14.21 %) |
Jul 14 2020 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Buy | M | 119.13 | 3,750 | 446,738 | 43,992 | 40.2 K to 44 K (+9.32 %) |
Jul 14 2020 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Buy | M | 77.40 | 23,809 | 1,842,817 | 40,242 | 16.4 K to 40.2 K (+144.89 %) |
Jul 14 2020 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Buy | M | 42.22 | 1,941 | 81,949 | 16,433 | 14.5 K to 16.4 K (+13.39 %) |
Jul 14 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | Chief Operating Off ... | Option Exercise | M | 77.10 | 46,639 | 3,595,867 | 28,064 | |
Jul 14 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | Chief Operating Off ... | Sell | S | 161.00 | 46,639 | 7,508,879 | 4,820 | 51.5 K to 4.8 K (-90.63 %) |
Jul 14 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | Chief Operating Off ... | Buy | M | 77.10 | 46,639 | 3,595,867 | 51,459 | 4.8 K to 51.5 K (+967.61 %) |
Jul 10 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | Chief Operating Off ... | Option Exercise | M | 77.10 | 297 | 22,899 | 74,703 | |
Jul 10 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | Chief Operating Off ... | Option Exercise | M | 42.22 | 10,939 | 461,845 | 3,125 | |
Jul 10 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | Chief Operating Off ... | Sell | S | 161.00 | 11,236 | 1,808,996 | 4,820 | 16.1 K to 4.8 K (-69.98 %) |
Jul 10 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | Chief Operating Off ... | Buy | M | 77.10 | 297 | 22,899 | 16,056 | 15.8 K to 16.1 K (+1.88 %) |
Jul 10 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | Chief Operating Off ... | Buy | M | 42.22 | 10,939 | 461,845 | 15,759 | 4.8 K to 15.8 K (+226.95 %) |
Jul 09 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Option Exercise | M | 9.14 | 22,265 | 203,502 | 44,530 | |
Jul 09 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Sell | S | 159.99 | 22,265 | 3,562,177 | 62,236 | 84.5 K to 62.2 K (-26.35 %) |
Jul 09 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Buy | M | 9.14 | 22,265 | 203,502 | 84,501 | 62.2 K to 84.5 K (+35.78 %) |
Jul 06 2020 | ALNY | ALNYLAM PHARMACEUT ... | HAMBURG MARGARET A | Director | Option Exercise | A | 148.77 | 4,581 | 681,515 | 4,581 | |
Jul 06 2020 | ALNY | ALNYLAM PHARMACEUT ... | HAMBURG MARGARET A | Director | Option Exercise | A | 148.77 | 4,581 | 681,515 | 4,581 | |
Jul 06 2020 | ALNY | ALNYLAM PHARMACEUT ... | BONNEY MICHAEL W | Director | Option Exercise | A | 148.77 | 4,581 | 681,515 | 4,581 | |
Jul 06 2020 | ALNY | ALNYLAM PHARMACEUT ... | Ausiello Dennis A | Director | Option Exercise | A | 148.77 | 4,581 | 681,515 | 4,581 | |
Jul 06 2020 | ALNY | ALNYLAM PHARMACEUT ... | Fanucci Marsha | Director | Option Exercise | A | 148.77 | 4,581 | 681,515 | 4,581 | |
Jul 06 2020 | ALNY | ALNYLAM PHARMACEUT ... | PAUL STEVEN M | Director | Option Exercise | A | 148.77 | 4,581 | 681,515 | 4,581 | |
Jul 06 2020 | ALNY | ALNYLAM PHARMACEUT ... | BONNEY MICHAEL W | Director | Option Exercise | A | 148.77 | 4,581 | 681,515 | 4,581 | |
Jul 06 2020 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILLIP A | Director | Option Exercise | A | 148.77 | 4,581 | 681,515 | 4,581 | |
Jul 06 2020 | ALNY | ALNYLAM PHARMACEUT ... | Ausiello Dennis A | Director | Option Exercise | A | 148.77 | 4,581 | 681,515 | 4,581 | |
Jul 06 2020 | ALNY | ALNYLAM PHARMACEUT ... | SCHULMAN AMY W | Director | Option Exercise | A | 148.77 | 4,581 | 681,515 | 4,581 | |
Jul 06 2020 | ALNY | ALNYLAM PHARMACEUT ... | Fanucci Marsha | Director | Option Exercise | A | 148.77 | 4,581 | 681,515 | 4,581 | |
Jul 06 2020 | ALNY | ALNYLAM PHARMACEUT ... | Reitan Colleen F | Director | Option Exercise | A | 148.77 | 4,581 | 681,515 | 4,581 |